Hybrid EANN-EA System for the Primary Estimation of Cardiometabolic Risk

被引:6
作者
Kupusinac, Aleksandar [1 ]
Stokic, Edita [2 ]
Kovacevic, Ilija [3 ]
机构
[1] Univ Novi Sad, Dept Comp & Control Engn, Fac Tech Sci, Trg Dositeja Obradov 6, Novi Sad 21000, Serbia
[2] Univ Novi Sad, Fac Med, Dept Endocrinol Diabet & Metab Disorders, Hajduk Veljkova 1, Novi Sad 21000, Serbia
[3] Univ Novi Sad, Fac Tech Sci, Dept Fundamentals Sci, Trg Dositeja Obradov 6, Novi Sad 21000, Serbia
关键词
Artificial neural network; Evolutionary algorithm; Cardiometabolic risk; Intelligent healthcare; CORONARY-HEART-DISEASE; ARTIFICIAL NEURAL-NETWORKS; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; LOGISTIC-REGRESSION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; SCREENING TOOL;
D O I
10.1007/s10916-016-0498-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The most important part of the early prevention of atherosclerosis and cardiovascular diseases is the estimation of the cardiometabolic risk (CMR). The CMR estimation can be divided into two phases. The first phase is called primary estimation of CMR (PE-CMR) and includes solely diagnostic methods that are non-invasive, easily-obtained, and low-cost. Since cardiovascular diseases are among the main causes of death in the world, it would be significant for regional health strategies to develop an intelligent software system for PE-CMR that would save time and money by extracting the persons with potentially higher CMR and conducting complete tests only on them. The development of such a software system has few limitations - dataset can be very large, data can not be collected at the same time and the same place (eg. data can be collected at different health institutions) and data of some other region are not applicable since every population has own features. This paper presents a MATLAB solution for PE-CMR based on the ensemble of well-learned artificial neural networks guided by evolutionary algorithm or shortly EANN-EA system. Our solution is suitable for research of CMR in population of some region and its accuracy is above 90 %.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Endocannabinoid system and cardiometabolic risk factors: A comprehensive systematic review insight into the mechanistic effects of omega-3 fatty acids
    Saleh-Ghadimi, Sevda
    Kheirouri, Sorayya
    Maleki, Vahid
    Jafari-Vayghan, Hamed
    Alizadeh, Mohammad
    LIFE SCIENCES, 2020, 250
  • [42] The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis
    Maryam Yavari
    Awat Feizi
    Fahimeh Haghighatdoost
    Azin Ghaffari
    Hassan Rezvanian
    Endocrine, 2021, 72 : 72 - 85
  • [43] Identification and Management of Patients at Elevated Cardiometabolic Risk in Canadian Primary Care: How Well Are We Doing?
    Teoh, Hwee
    Despres, Jean-Pierre
    Dufour, Robert
    Fitchett, David H.
    Goldin, Lianne
    Goodman, Shaun G.
    Harris, Stewart B.
    Langer, Anatoly
    Lau, David C. W.
    Lonn, Eva M.
    Mancini, G. B. John
    McFarlane, Philip A.
    Poirier, Paul
    Rabasa-Lhoret, Remi
    Tan, Mary K.
    Leiter, Lawrence A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (08) : 960 - 968
  • [44] The influence of parathyroidectomy on cardiometabolic risk factors in patients with primary hyperparathyroidism: a systematic review and meta-analysis
    Yavari, Maryam
    Feizi, Awat
    Haghighatdoost, Fahimeh
    Ghaffari, Azin
    Rezvanian, Hassan
    ENDOCRINE, 2021, 72 (01) : 72 - 85
  • [45] Visceral fat, cardiometabolic risk factors, and nocturnal blood pressure fall in young adults with primary hypertension
    Miazgowski, Tomasz
    Taszarek, Aleksandra
    Miazgowski, Bartosz
    JOURNAL OF CLINICAL HYPERTENSION, 2019, 21 (09) : 1406 - 1414
  • [46] Evaluation of a culturally-adapted lifestyle intervention to treat elevated cardiometabolic risk of Latino adults in primary care (Vida Sana): A randomized controlled trial
    Rosas, Lisa G.
    Lv, Nan
    Xiao, Lan
    Lewis, Megan A.
    Zavella, Patricia
    Kramer, M. Kaye
    Luna, Veronica
    Ma, Jun
    CONTEMPORARY CLINICAL TRIALS, 2016, 48 : 30 - 40
  • [47] Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection
    van Daalen, Kim Robin
    Zhang, Dudan
    Kaptoge, Stephen
    Paige, Ellie
    Di Angelantonio, Emanuele
    Pennells, Lisa
    LANCET GLOBAL HEALTH, 2024, 12 (08): : e1343 - e1358
  • [48] The Web system for coronary disease risk estimation by logistic regression ("CHD risk")
    Martinovic, Goran
    Meseljevic, Stjepan
    Dreniandevic-Peric, Ines
    MEDICINSKI GLASNIK, 2009, 6 (01) : 78 - 88
  • [49] Evolving Concepts of the SCORE System: Subtracting Cholesterol from Risk Estimation: A Way for a Healthy Longevity?
    Natale, Francesco
    Franzese, Rosa
    Marotta, Luigi
    Mollo, Noemi
    Solimene, Achille
    Luisi, Ettore
    Gentile, Carmine
    Loffredo, Francesco S.
    Golino, Paolo
    Cimmino, Giovanni
    LIFE-BASEL, 2024, 14 (06):
  • [50] Evaluation of lifestyle interventions to treat elevated cardiometabolic risk in primary care (E-LITE): a randomized controlled trial
    Ma, Jun
    King, Abby C.
    Wilson, Sandra R.
    Xiao, Lan
    Stafford, Randall S.
    BMC FAMILY PRACTICE, 2009, 10